16-20348509-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1
The NM_003361.4(UMOD):c.792G>A(p.Val264Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,608,538 control chromosomes in the GnomAD database, including 24,479 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2000 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22479 hom. )
Consequence
UMOD
NM_003361.4 synonymous
NM_003361.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0900
Publications
21 publications found
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
- autosomal dominant medullary cystic kidney disease with or without hyperuricemiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- glomerulocystic kidney disease with hyperuricemia and isosthenuriaInheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
- familial juvenile hyperuricemic nephropathy type 1Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant medullary cystic kidney disease with hyperuricemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 16-20348509-C-T is Benign according to our data. Variant chr16-20348509-C-T is described in ClinVar as [Benign]. Clinvar id is 94131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.792G>A | p.Val264Val | synonymous_variant | Exon 3 of 11 | 5 | NM_003361.4 | ENSP00000379442.5 | ||
UMOD | ENST00000396134.6 | c.891G>A | p.Val297Val | synonymous_variant | Exon 4 of 12 | 2 | ENSP00000379438.2 | |||
UMOD | ENST00000570689.5 | c.792G>A | p.Val264Val | synonymous_variant | Exon 3 of 11 | 5 | ENSP00000460548.1 |
Frequencies
GnomAD3 genomes AF: 0.155 AC: 23544AN: 152186Hom.: 1994 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
23544
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.156 AC: 37266AN: 239420 AF XY: 0.158 show subpopulations
GnomAD2 exomes
AF:
AC:
37266
AN:
239420
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.172 AC: 250277AN: 1456234Hom.: 22479 Cov.: 36 AF XY: 0.171 AC XY: 124248AN XY: 724482 show subpopulations
GnomAD4 exome
AF:
AC:
250277
AN:
1456234
Hom.:
Cov.:
36
AF XY:
AC XY:
124248
AN XY:
724482
show subpopulations
African (AFR)
AF:
AC:
3751
AN:
33478
American (AMR)
AF:
AC:
6728
AN:
44388
Ashkenazi Jewish (ASJ)
AF:
AC:
3543
AN:
26086
East Asian (EAS)
AF:
AC:
194
AN:
39658
South Asian (SAS)
AF:
AC:
13647
AN:
85986
European-Finnish (FIN)
AF:
AC:
11036
AN:
49510
Middle Eastern (MID)
AF:
AC:
1134
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
200316
AN:
1111102
Other (OTH)
AF:
AC:
9928
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
14895
29790
44686
59581
74476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.155 AC: 23568AN: 152304Hom.: 2000 Cov.: 33 AF XY: 0.156 AC XY: 11614AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
23568
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
11614
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
4314
AN:
41582
American (AMR)
AF:
AC:
2700
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
485
AN:
3470
East Asian (EAS)
AF:
AC:
58
AN:
5180
South Asian (SAS)
AF:
AC:
709
AN:
4828
European-Finnish (FIN)
AF:
AC:
2390
AN:
10606
Middle Eastern (MID)
AF:
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12253
AN:
68006
Other (OTH)
AF:
AC:
349
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1055
2110
3165
4220
5275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
371
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Mar 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
Oct 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial juvenile hyperuricemic nephropathy type 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 3
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.